SCHEMBL3456432

SCHEMBL3456432

CCNC(=O)c1cncs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.49
ACACB O00763 3/20 0.43
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
KIF11 P52732 1/20 0.41
ABL1 P00519 1/20 0.40
ICAM1 P05362 1/20 0.38
SELE P16581 1/20 0.38
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
NAMPT P43490 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
GRM4 Q14833 1/20 0.36
GRM5 P41594 1/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PIK3CD O00329 1/20 0.35
IDO1 P14902 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9326293 0.86 KMT2A (0.46) KMT2AACACBKIF11ABL1HRH3
SCHEMBL28202712 0.81 KMT2A (0.45) KMT2AACACBKIF11ABL1GAA
SCHEMBL5196227 0.81 KMT2A (0.48) KMT2AACACBHDAC1KIF11ABL1
SCHEMBL9331210 0.80 KMT2A (0.47) KMT2AACACBABL1ICAM1SELE
SCHEMBL2780654 0.79
SCHEMBL343489 0.79
SCHEMBL3425315 0.78
Hydrochloric Acid SCHEMBL23411737 0.77 KMT2A (0.51) KMT2AACACBHDAC1HDAC6KIF11
SCHEMBL24568381 0.76 ACACB (0.55) KMT2AACACBKIF11GAAALDH1A1
SCHEMBL15296855 0.76 KMT2A (0.44) KMT2AACACBHDAC1KIF11ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023229380-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF 주식회사 엘지화학 2023-11-30 WO claimed
US-12583851-B2 Heteroaryl-substituted pyrazine derivatives as pesticides ELANCO ANIMAL HEALTH GMBH (DE) 2026-03-24 US disclosed
WO-2023229380-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF 주식회사 엘지화학 2023-11-30 WO disclosed
US-20230145481-A1 SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS DICE ALPHA, INC. 2023-05-11 US disclosed
US-20230101819-A1 SMYD Inhibitors EPIZYME INC (US) 2023-03-30 US disclosed
CN-109071526-B Acid addition salts of piperazine derivatives 阿森纽荣股份公司 2023-02-28 CN disclosed
US-20230023326-A1 HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES ELANCO ANIMAL HEALTH GMBH (DE) 2023-01-26 US disclosed
US-20210198252-A1 SMYD INHIBITORS EPIZYME INC (US) 2021-07-01 US disclosed
US-20190322660-A1 SMYD INHIBITORS Epizyme, Inc. 2019-10-24 US disclosed
US-10266526-B2 Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer Epizyme, Inc. (US) 2019-04-23 US disclosed
EP-3419976-A1 ACID ADDITION SALTS OF PIPERAZINE DERIVATIVES Asceneuron SA (CH) 2019-01-02 EP disclosed
CN-109071526-A The acid-addition salts of bridged piperazine derivatives 阿森纽荣股份公司 2018-12-21 CN disclosed
US-20170355695-A1 SMYD Inhibitors Epizyme, Inc. (US) 2017-12-14 US disclosed
WO-2017144637-A1 ACID ADDITION SALTS OF PIPERAZINE DERIVATIVES ASCENEURON S. A. (CH) 2017-08-31 WO disclosed
CN-107108601-A Glycosidase inhibitor 阿森纽荣股份公司 2017-08-29 CN disclosed
CN-103998434-A Thiazole derivative as DHODH inhibitor and use thereof UNIV EAST CHINA SCIENCE & TECH 2014-08-20 CN disclosed
WO-2007143597-A9 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2010-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12583851-B2 Heteroaryl-substituted pyrazine derivatives as pesticides CBR3, CYCS, CWC15 KMT2A 3192/4885ACACB 1541/4885HDAC4 1882/4885
US-20230023326-A1 HETEROARYL-SUBSTITUTED PYRAZINE DERIVATIVES AS PESTICIDES DDT, PRXL2A, CAT KMT2A 2752/4885ACACB 4127/4885HDAC4 2508/4885
US-20230145481-A1 SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS IL17A, IL2, IL23R KMT2A 3300/4885ACACB 594/4885HDAC4 896/4885
US-10266526-B2 Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer SMYD3, SMYD2, SNRPD3 KMT2A 360/4885ACACB 2316/4885HDAC4 705/4885
US-20170355695-A1 SMYD Inhibitors SMYD3, SMYD2, SMURF2 KMT2A 348/4885ACACB 1838/4885HDAC4 1369/4885
US-20210198252-A1 SMYD INHIBITORS SMYD3, SMYD2, SMURF2 KMT2A 355/4885ACACB 1909/4885HDAC4 1391/4885
US-20190322660-A1 SMYD INHIBITORS SMYD2, SMYD3, SMURF2 KMT2A 420/4885ACACB 2377/4885HDAC4 2422/4885
US-20230101819-A1 SMYD Inhibitors SMYD3, SMYD2, SMURF2 KMT2A 364/4885ACACB 1837/4885HDAC4 1391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.